Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Summary

This is a single-arm pilot feasibility study evaluating the combination of Botensilimab and Balstilimab with Radiation Therapy (RT) in Non-Microsatellite Instability High (MSI-H) or Proficient Mismatch Repair (pMMR) chemorefractory colorectal cancer (CRC) with liver metastasis.

Timeline

Start

2026-05-12

Primary completion

2027-01-01

Completion

2027-09

Drugs

Indications